CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin

125 $

This formulation combines a GHRH analog (CJC-1295) with a selective GHS-R1a receptor agonist (Ipamorelin) in a single vial, supplied as a lyophilized research blend for studying dual-pathway, synergistic GH-axis activation.

Specifications

Product: CJC-1295 + Ipamorelin

Form: Lyophilized powder

Purity: High purity research grade

Use: Research use only

Storage

Store refrigerated at 2–8°C. For long-term storage, keep frozen according to laboratory protocols. Protect from heat, moisture, and direct light.

Package Includes

1 × Sterile research vial

Category: Tag:

Description

Because GHRH and ghrelin-receptor agonists act on distinct receptors that converge on the same somatotroph cells, this combination is used in research to study synergistic versus additive effects on growth hormone pulse amplitude and frequency. It offers investigators a single-vial format for combination-pathway experiments that would otherwise require separate reconstitution and co-administration of two compounds.

Research Applications

  • Synergistic GHRH/GHS-R1a pathway research
  • GH pulse amplitude and frequency studies
  • Combination peptide formulation research
  • Comparative studies against single-agent GH secretagogues
  • Somatotroph cell signaling models
COA download
Disclaimer

For laboratory research use only. Not for human consumption, clinical use, veterinary use, diagnosis, or therapeutic application.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 + Ipamorelin”

Your email address will not be published. Required fields are marked *

Related products